Acumen Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -45 | -45 | ||
EBITDA | -25,109 | -25,383 | -39,857 | -27,728 |
EBIT | -25,154 | -39,904 | -27,773 | |
Net Income | -25,138 | -26,451 | -40,950 | -28,796 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,096 | -30,489 | -31,841 | -34,200 |
Cash | 53,989 | 46,832 | 36,810 | 30,159 |
Basic Shares | 60,561 | 60,573 | 60,573 | 60,525 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -184 | -178 | -42,318 | -169 |
EBITDA | -123,832 | -98,083 | -51,606 | -42,687 |
EBIT | -98,261 | -51,790 | -42,856 | |
Net Income | -121,335 | -102,329 | -52,371 | -42,856 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 7,939 | |||
Free Cash Flow | -115,626 | -86,231 | -43,085 | -35,314 |
Cash | 53,989 | 35,627 | 66,886 | 130,101 |
Basic Shares | 60,561 | 60,013 | 48,609 | 40,601 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.41 |
2025-09-30 | -$0.44 |
2025-06-30 | -$0.68 |
